Abir Arfaoui
Overview
Explore the profile of Abir Arfaoui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arfaoui A, Rioualen C, Azzoni V, Pinna G, Finetti P, Wicinski J, et al.
EMBO Mol Med
. 2019 Sep;
11(10):e9930.
PMID: 31476112
Therapeutic resistance is a major clinical challenge in oncology. Evidence identifies cancer stem cells (CSCs) as a driver of tumor evolution. Accordingly, the key stemness property unique to CSCs may...
2.
Arfaoui A, Douik H, Kablouti G, Chaaben A, Handiri N, Zid Z, et al.
J BUON
. 2016 Aug;
21(3):732-9.
PMID: 27569097
Purpose: To find a possible association between the Mouse Double Minute 2(MDM2) 344T>A, alone and in combination with p53 72 Arg/Pro polymorphism, and resistance to anthracycline-based chemotherapy of breast cancer...
3.
Arfaoui A, Douik H, Kablouti G, Chaaben A, Handiri N, Zid Z, et al.
Anticancer Res
. 2015 Mar;
35(3):1763-9.
PMID: 25750340
Background/aim: We undertook a case-control and a case-case study to examine the possible association of p53 codon72 polymorphism with the breast cancer risk and resistance to anthracycline-based chemotherapy. Patients And...